trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

The World Health Organization Global Influenza Surveillance Network provides virological information used to select strains for influenza vaccine production.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
4 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that the World Health Organization Global Influenza Surveillance Network provides virological information used to select strains for influenza vaccine production?

Yes. The World Health Organization Global Influenza Surveillance Network provides vital virological and genetic data used globally to monitor viral evolution and select strains for influenza vaccine production.

Verdict: SUPPORTED · 4 sources for, 0 against · Last checked

The analysis

The retrieved papers consistently confirm that the WHO global influenza surveillance networks (such as GISRS) track viral circulation, genetic diversity, and antigenic characteristics to provide the foundational data required for seasonal influenza vaccine strain selection.

Evidence for · 4
2018
The paper highlights that the WHO Global Influenza Surveillance and Response System (GISRS) provides information and virus sharing to maintain the efficacy of seasonal influenza vaccines.
Get citation
Hay, A. J. & McCauley, J. W. (2018). The WHO global influenza surveillance and response system (<scp>GISRS</scp>)—A future perspective. doi.org. https://doi.org/10.1111/irv.12565

See more details
More for · 3
2026
The study emphasizes the importance of integrated genomic surveillance and timely antigenic characterization to support evidence-based vaccine strain selection.
Get citation
F, B., N, P., G, C., F, S., M, G., & M, C. (2026). Influenza A(H3N2) Subclade K (J.2.4.1): Molecular Characterization, Antigenic Divergence, and Global Spread During the 2025/26 Season.. doi.org. https://doi.org/10.3390/idr18020037

2026
The research underscores the necessity of continuous genomic surveillance of circulating influenza viruses to inform vaccine strain selection.
Get citation
C, S., A, C., N, G., AK, I., M, S., M, L., B, W. O. K., G, T., JB, O., E, D., A, D., S, G., H, O., & Z, T. (2026). Genomic Surveillance and Phylogenetic Analysis of Influenza A(H1N1) pdm09 and A(H3N2) Viruses in Burkina Faso, 2024.. doi.org. https://doi.org/10.1155/av/6901688

2026
The findings demonstrate that integrated surveillance is crucial for monitoring viral evolution and assessing vaccine relevance.
Get citation
A, G., A, M., A, U., A, Y., A, K., M, S., A, K., A, P., A, F., K, S., A, A., D, J., L, K., M, S., A, K., & M, S. (2026). Antigenic and Molecular Genetic Evolution of Influenza Viruses in Kazakhstan from 2017 to 2025.. doi.org. https://doi.org/10.3390/biology15181640

What does the evidence say?

The retrieved papers consistently confirm that the WHO global influenza surveillance networks (such as GISRS) track viral circulation, genetic diversity, and antigenic characteristics to provide the foundational data required for seasonal influenza vaccine strain selection.

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work